pharmaphorum7h
Neurogene falls again on Rett gene therapy side effects
In an update posted today, Neurogene said that the "emerging treatment-related serious adverse event (SAE)" was a case of ...
pharmaphorum8h
AI could 'cut ECG result wait times and speed up treatment'
The trial of the PanEcho software, presented at the American Heart Association (AHA) congress in Chicago, suggests that it ...
pharmaphorum10h
AbbVie bags EU nod for key drug from ImmunoGen takeover
AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically ...
pharmaphorum10h
Tirzepatide gets a big win in obesity-related heart failure
"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...
pharmaphorum12h
Scaling AI in life sciences: From automation to strategic transformation
AI-powered chatbots will enhance HCP engagement, while comprehensive customer lifetime value prediction will enable more ...
pharmaphorum8h
AI cuts wait times for ECG results and speeds up treatment
The trial of the PanEcho software, presented at the American Heart Association (AHA) congress in Chicago, suggests that it ...
pharmaphorum12h
Syndax gets FDA okay for first-in-class leukaemia drug
Revuforj is Syndax's second first-in-class approval for 2024, coming after the company and partner Incyte got a green light ...
pharmaphorum2d
NHS pilots iPhone app to rule out throat cancer
NHS England has started a pilot trial of an iPhone app and device combination that could be used by nursing staff to speed up reviews of suspected throat cancer. The technology consists of an ...